'cron' => '1760758212', 'cron' => '1760760012', 'cron' => '1760761811', 'cron' => '1760763611', 'cron' => '1760765410', 'cron' => '1760767214', 'cron' => '1760769013', 'cron' => '1760770820', 'cron' => '1760772610', 'cron' => '1760774413', 'cron' => '1760776213', 'cron' => '1760778010', 'cron' => '1760779812', 'cron' => '1760781612', 'cron' => '1760783413', 'cron' => '1760785212', 'cron' => '1760787014', 'cron' => '1760788815', 'cron' => '1760790612', ]; Blogs | sterlingcapartners.com
logo

Latest Financial Updates

Read the latest financial news update from our blog

Pathway acquired by US telehealth firm Doximity for $63 million USD
Pathway acquired by US telehealth firm Doximity for $63 million USD

Doximity now beta testing a product with Pathway's AI-powered search technology and medica...

Admin | Finance | 10 weeks ago

August Health Receives $29M Series B Round
August Health Receives $29M Series B Round

August Health Receives $29M Series B Round Back to Home SAN FRANCISCO, CA, August Health...

Admin | Finance | 10 weeks ago

Zymeworks Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ZYME)
Zymeworks Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ZYME)

Seeking Alpha's transcripts team is responsible for the development of all of our transcri...

Admin | Finance | 10 weeks ago

Zymeworks Inc. (ZYME) Q2 2025 Earnings Call Transcript
Zymeworks Inc. (ZYME) Q2 2025 Earnings Call Transcript

Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET C...

Admin | Finance | 10 weeks ago

What Would Happen If Lyndsey Sweeney Started Gardening and Baking Bread?
What Would Happen If Lyndsey Sweeney Started Gardening and Baking Bread?

Thank you, Kerjanga N. ($70), for your exceedingly generous subscription to this site -- I...

Admin | Finance | 10 weeks ago

Iovance falls after missing Q2 expectation (IOVA:NASDAQ)
Iovance falls after missing Q2 expectation (IOVA:NASDAQ)

Iovance Biotherapeutics (NASDAQ:IOVA) shares tanked after the company failed to meet top-l...

Admin | Finance | 10 weeks ago

Heron Therapeutics raises adjusted EBITDA guidance to $9M-$13M for 2025 amid commercial restructuring and ZYNRELEF J-code milestone (NASDAQ:HRTX)
Heron Therapeutics raises adjusted EBITDA guidance to $9M-$13M for 2025 amid commercial restructuring and ZYNRELEF J-code milestone (NASDAQ:HRTX)

The earnings call insights are compilations of earnings call transcripts and other content...

Admin | Finance | 10 weeks ago

Trumps team is expanding the search for the Fed Chair
Trumps team is expanding the search for the Fed Chair

The Wall Street Journal is reporting that the Pres. team is expanding the search for the n...

Admin | Finance | 10 weeks ago

Join Our Newsletter

join our newsletter to receive update from us